BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35951769)

  • 1. A novel point-of-care device accurately measures thyrotropin in whole blood, capillary blood and serum.
    Kahaly GJ; Lotz J; Walder S; Hammad C; Krämer R; Frommer L; König J; Wolf J; Gottwald-Hostalek U; Urgatz B; Lackner KJ
    Clin Chem Lab Med; 2022 Sep; 60(10):1607-1616. PubMed ID: 35951769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Age-Specific Serum Thyrotropin Reference Range for the Diagnosis of Thyroid Diseases in Older Adults: A Cross-Sectional Survey in China.
    Zhai X; Zhang L; Chen L; Lian X; Liu C; Shi B; Shi L; Tong N; Wang S; Weng J; Zhao J; Teng X; Yu X; Lai Y; Wang W; Li C; Mao J; Li Y; Fan C; Li L; Shan Z; Teng W
    Thyroid; 2018 Dec; 28(12):1571-1579. PubMed ID: 30351201
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluated reference intervals for serum free thyroxine and thyrotropin using the conventional outliner rejection test without regard to presence of thyroid antibodies and prevalence of thyroid dysfunction in Japanese subjects.
    Takeda K; Mishiba M; Sugiura H; Nakajima A; Kohama M; Hiramatsu S
    Endocr J; 2009; 56(9):1059-66. PubMed ID: 19738362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the AFIAS-1 thyroid-stimulating hormone point of care test and comparison with laboratory-based devices.
    Dierks S; Andag R; Gauss F; Budde K; Francke P; Peschka M; Fischer A; Schanz J; Petersmann A
    Clin Chem Lab Med; 2022 Jun; 60(7):1031-1038. PubMed ID: 35451300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitive detection and quantitation of thyroid-stimulating hormone (TSH) from capillary/fingerstick and venepuncture whole-blood using fluorescence-based rapid lateral flow immunoassay (LFIA).
    Shurbaji S; Al Tamimi F; Al Ghwairi MM; El Chaar D; Younes S; Majdalawieh AF; Pintus G; Al-Dewik N; Nasrallah GK
    Heliyon; 2023 Oct; 9(10):e20589. PubMed ID: 37842620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
    Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
    Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-step quantitative thyrotropin assay for the detection of hypothyroidism in point-of-care conditions.
    von Lode P; Hagrén V; Palenius T; Lövgren T
    Clin Biochem; 2003 Mar; 36(2):121-8. PubMed ID: 12633761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blood spot thyrotropin method is not adequate to screen for hypothyroidism in the elderly living in abundant-iodine intake areas: comparison to sensitive thyrotropin measurements.
    Takáts IK; Péter F; Rimanóczi E; Dohán O; Földes J; Vadász J; Feldkamp J; Szilágyi G; Góth M; Kovács L; Radácsi A; Szabolcs I
    Thyroid; 2000 Jan; 10(1):79-85. PubMed ID: 10691317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive thyrotropin assays: analytic and clinical performance criteria.
    Klee GG; Hay ID
    Mayo Clin Proc; 1988 Nov; 63(11):1123-32. PubMed ID: 3057295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum prolactin response to thyrotropin-releasing hormone in normal subjects and in patients with thyroid diseases (author's transl)].
    Onishi T; Miyai K; Kumahara Y
    Nihon Naibunpi Gakkai Zasshi; 1975 Mar; 51(3):161-5. PubMed ID: 808433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Evaluation of the Immune Colloidal Gold Method for Rapid Qualitative and Quantitative Measurement of Thyroid-Stimulating Hormone as an Assay for Hypothyroidism.
    Wang T; Sheng S; Ruan M; Yan J; Gu J; Jiang Y; Gao Y; Lu H
    Adv Ther; 2016 Nov; 33(11):2001-2011. PubMed ID: 27605368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved sensitivity of serum thyrotropin measurements. Studies on serum sex hormone-binding globulin in patients with reduced serum thyrotropin.
    Faber J; Gam A; Siersbaek-Nielsen K
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):535-40. PubMed ID: 2256433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory and diagnostic performance of a coated well immunoradiometric assay for serum thyrotrophin.
    Gow SM; Nicol K; Seth J; Caldwell G; Toft AD; Beckett GJ
    Ann Clin Biochem; 1987 May; 24 ( Pt 3)():273-8. PubMed ID: 3606012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotroph function assessed by sensitive measurement of thyrotropin with three immunoradiometric assay kits: analytical evaluation and comparison with the thyroliberin stimulation test.
    Wians FH; Jacobson JM; Dev J; Heald JI; Ortiz G
    Clin Chem; 1988 Mar; 34(3):568-75. PubMed ID: 3127084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of thyroid dysfunction in a Large Southern European Population. Analysis of modulatory factors. The APNA study.
    Santos Palacios S; Llavero Valero M; Brugos-Larumbe A; Díez JJ; Guillén-Grima F; Galofré JC
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):367-375. PubMed ID: 29893010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.